相关实验视频

Updated: May 22, 2025

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.0K

新诊断的质母细胞瘤的粒细胞-巨细胞殖民地刺激因子

Caineng Cao1, Le Wang2, Feng Jiang1

  • 1Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences; Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, China.

Neoplasia (New York, N.Y.)
|March 16, 2025
PubMed
概括

这项研究发现,将低分离强度调节辐射疗法 (IMRT) 与泰莫索洛米德和粒细胞巨细胞殖民地刺激因子 (GM-CSF) 结合起来,是新诊断的质母细胞瘤 (GBM) 的可行且安全的治疗方法. 该疗法显示了有希望的6个月无进展生存率.

关键词:
转基因-CSFF是什么意思质母细胞瘤 (glioblastoma) 是一个低分离辐射疗法 低分离辐射疗法免疫治疗是一种免疫疗法.泰莫佐洛米德 (Temozolomide) 是一种一种

更多相关视频

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds09:18

Image-Guided Resection of Glioblastoma and Intracranial Implantation of Therapeutic Stem Cell-seeded Scaffolds

Published on: July 16, 2018

8.2K
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

15.7K

相关概念视频

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K